Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Is AT&T Stock a Buy for 2024?


With 2024 upon us, telecom stalwart AT (NYSE: T) looks like it's turned a corner on a multi-year transformation. After John Stankey took over as CEO in July 2020, he refocused the company on its telecommunications business, divesting the entertainment assets acquired under previous management.

Because of this transition, the last few years weren't kind to investors. The company cut its dividend in 2022, and for much of 2023, AT's stock languished, remaining well below its 52-week high of $19.99 reached last April.

But shares gradually began to rise toward the end of 2023, and this year, the stock was upgraded by J.P. Morgan to overweight. So 2024 may be the year to pick up AT shares. Here's a look into the company to determine if now is the time to buy.

Continue reading


Source Fool.com

Allergy Therapeutics PLC Aktie

0,057 €
-0,87 %
Heute erleidet Allergy Therapeutics PLC einen kleinen Verlust von -0,87 %.

Like: 0
T
Teilen

Kommentare